Treace Medical Concepts, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-59.0M | $-55.7M | $-49.5M | $-42.8M | $-20.6M | $-3.7M | $-4.3M |
| Depreciation & Amortization | $10.6M | $8.4M | $5.4M | $2.1M | $685.0K | $1.2M | $793.0K |
| Depreciation | — | — | — | — | — | — | — |
| Amortization | $1.0M | $1.0M | $500.0K | $0 | — | — | — |
| Stock-Based Compensation | $33.8M | $30.6M | $17.4M | $8.1M | $3.4M | $919.0K | $815.0K |
| Net Cash from Operating Activities | $-16.0M | $-37.2M | $-34.6M | $-30.6M | $-17.2M | $-4.5M | $-7.7M |
| Investing Activities | |||||||
| Capital Expenditures | $13.5M | $11.6M | $11.5M | $14.8M | $2.7M | $1.1M | $1.2M |
| Business Acquisitions | $0 | $0 | $20.0M | $0 | $0 | — | — |
| Net Cash from Investing Activities | $13.3M | $35.4M | $-81.3M | $-76.5M | $-2.7M | $-1.1M | $-1.2M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $2.1M | $160.0K | $109.4M | $20.8M | $107.7M | $11.5M | $19.7M |
| Net Change in Cash | $-642.0K | $-1.6M | $-6.5M | $-86.4M | $87.8M | $5.9M | $10.9M |
| Free Cash Flow | $-29.5M | $-48.8M | $-46.0M | $-45.5M | $-19.9M | $-5.6M | $-8.9M |